The International 22nd Puijo Symposium:
“Physical Exercise, Ageing and Disability - Current Evidence”
Scientific Program
June 24, 2014
SOURCES OF EVIDENCE AND SCIENTIFIC RESEARCH METHODS IN EXERCISE MEDICINE
Update on epidemiology in exercise medicine – strengths and shortcomings, dr I-Min Lee, USA
Randomized clinical trials in exercise medicine – strengths and shortcoming, Dr William E. Kraus, USA
Pitfalls in statistical analyses in exercise medicine - how to avoid? Dr Harold W Kohl III
Comparative effectiveness research in exercise medicine, Dr Barbara Ainsworth, USA
EXERCISE AND FITNESS: ULTIMATE DETERMINANTS OF HEALTH
Cardiorespiratory fitness: strongest predictor of morbidity and mortality? Dr Arthur Leon, USA
Cardiorespiratory fitness: badly underused tool in clinical decision making? Dr Jonathan Myers, USA
Physical inactivity: a growing pandemic! Dr David Dunstan, Australia
MOLECULAR BIOLOGY IN EXERCISE MEDICINE
Gene-physical activity interactions - the current status of knowledge with reference to chronic diseases, Dr Tuomo Rankinen, USA
Epigenetics and exercise, Dr Charlotte Ling, Sweden
Exercise, muscle physiology and molecular biology - what do we know today, what should we know tomorrow? Dr Eric Richter, Denmark
June 25, 2014
FROM SCIENCE TO CLINICAL PRACTICE I - Cardiovascular diseases
Aerobic exercise in atherosclerotic vascular diseases - molecular mechanisms, Dr Volker Adams, Germany
Extreme exercise and cardiovascular health: the risk-protection paradox, Dr Barry Franklin, USA
Low or high intensity exercise in CHD - what is the evidence? Dr Arto Hautala, Finland
Clinical trials of statin myopathy, Dr Paul Thompson, USA
FROM SCIENCE TO CLINICAL PRACTICE I - Cardiovascular diseases
Exercise in the treatment of chronic heart failure - physiological mechanisms, Dr Martin Halle, Germany
Evidence-based exercise prescription for chronic heart failure, Dr Jari Laukkanen, Finland
Exercise in the treatment of hypertension - physiological mechanisms, Dr Danny Green, Australia
Evidence-based exercise prescription for hypertension, Dr Arno Schmidt-Trucksäss, Switzerland
THE FUTURE OF SCIENTIFIC FOCUS IN EXERCISE MEDICINE RESEARCH
Do we need something else in addition to pathophysiology and exercise physiology? Dr Michael J. Joyner, USA
Genomics and Personalized Exercise Medicine, Dr Claude Bouchard, USA
Surrogate measures or hard end points? Dr Ulf de Faire, Sweden
June 26, 2014
FROM SCIENCE TO CLINICAL PRACTICE II - Metabolic diseases
Exercise in the treatment of obesity and cardiometabolic risk profile, Dr Jean-Pierre Després, Canada
Evidence-based exercise prescription for obesity, Dr Robert Ross, Canada
Exercise in the treatment of type 2 diabetes - physiological mechanisms of aerobic and resistance training, Dr John Hawley, Australia
Evidence-based exercise prescription for type 2 diabetes, Dr Allan Vaag, Denmark
FROM SCIENCE TO CLINICAL PRACTICE II - Metabolic diseases
Metabolomics in exercise medicine - additional value behind traditional biomarkers? Dr Marja-Riitta Taskinen, Finland
Exercise, ageing and mitochondrial biogenesis - implications for health, Dr Sreekumaran Nair, USA
FROM SCIENCE TO CLINICAL PRACTICE III - Pulmonary diseases and cancer
Exercise Limitations in COPD: Implications for Rehabilitation, Dr Jerome Dempsey, USA
Evidence-based exercise prescription for chronic obstructive pulmonary disease, Dr Heikki Tikkanen, Finland
Resistance training in the treatment of malignant neoplasms, Dr Harri Suominen, Finland
Evidence-based exercise prescription for oncology, Dr Lee Jones, USA
June 27, 2014
FROM SCIENCE TO CLINICAL PRACTICE V - Musculoskeletal diseases
Exercise in the treatment of osteoarthritis - physiological mechanisms, Dr Jari Arokoski, Finland
Evidence-based exercise prescription for osteoarthritis, Dr Urho Kujala, Finland
Exercise in the treatment of osteoporosis - physiological mechanisms, Dr Dennis Taaffe, Australia
FROM SCIENCE TO CLINICAL PRACTICE V - Musculoskeletal diseases
Evidence-based exercise prescription for osteoporosis, Dr Ilkka Vuori, Finland
Exercise in the treatment of frailty - physiological mechanisms, Dr Tommy Cederholm, Sweden
Evidence-based exercise prescriptions for the prevention of frailty, Dr Loretta DiPietro, USA
Global challenges for exercise medicine by 2050, Dr Steven N. Blair, USA